Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

THE COUNT--->ALL

There's a new article on us at

http://www.reducinglengthofstay.org.uk/innews.html

Just click on the Clinical Services Journal article dated September 07.
Happy reading.

Regards,

THE COUNT!

The Count-------Thanks for that, I've not read the new article but your previous 2 posts and also post 451 again, like many aim stocks we seem to need an abundance of patience for them, I have many such stocks and from time to time need reminding as to why I invested in a particular company in the first place. As a result I have bought more today. I still like IPX, though up 10%ish.
2517

The Count.....Yes,thanks re your reports. It beggars belief that the sales don't reflect the positive reports/trials of the Cardio products.

I wonder if the RNS release subject is anything to do with the appiontment of Sir Ara Darzi (my post 30/06/07) to the NHS government advisory group. It's very good news, but don't hold your breath for a result. The wheels of NHS bureaucracy as we know turn very slowly.

Can't understand why the sp has not risen at least a few points, but probably because there is still very little interest in this share. Will be amazed if there is not some largish trades later, especialy to show as Late Trades.
With the evaluation being what surely must be a forgone conclusion from all the positive trials/results on record this must be a share to be in. What more evidence of the CardioQ viability is required? It's not rocket science.
So if the NHS advisory group get their finger out, the next 6 months should be very productive indeed.
Still being patient, but frustration begining to take over.

greekman--------know what you mean, I almost sold out for the same reason, but DEMG must be a share with a future so I did the opposite on friday and bought more, however I did get fed up waiting for LEAD and sold them and the very disappointing APN (sizeable loss on APN). Also back in on AHT.
2517

THE COUNT--->ALL

Heads up pussycats.....an interesting site has gone live.

Maybe, just maybe, all the quiet and diplomatic work by companies like DEMG and other interested parties are beginning ot bear fruit. The pressure must now really be on for this technology to be adopted in the NHS.

Take a look at this site.....

http://www.technologyadoptionhub.nhs.uk/

It's just recently gone live.

If you then click on the news section and then on the news article dated 3-10-07, you should see mention of our very own Ewan Phillips, FD of DEMG.

I am currently browsing through the website to see what else may be lurking therein.

Oh, fuck it. I've posted the link anyway so here is a copy of the article....



NHS National Technology Adoption Hub - National Launch Event

The NHS National Technology Adoption Hub formally launched in Manchester on Friday 28 September 2007.

The world's first National Technology Adoption Hub for healthcare has been unveiled in Manchester.

The Technology Adoption Hub is aimed at helping the NHS better implement new cost-effective, life-saving technologies. Hosted by the Central Manchester and Manchester Children's University Hospital Trust, it will take up 15 innovative medical technologies over the next three years, and examine how they can be put into practice in the quickest, most effective way to improve NHS productivity.

Margaret Parton, CEO of the National Technology Adoption Hub, unveiled the Hub to over 150 leading clinicians, NHS managers, academics and representatives from the medical technology industry at an event at Manchester's Whitworth Art Gallery. The Hub is supported by Professor Lord Ara Darzi, who is currently leading a whole-scale review of the NHS: "Schemes such as the National Technology Adoption Hub shows the extent of the innovation and development within the NHS. It is encouraging to see the NHS continually striving to find the best standards of care, using the latest available techniques, for its patients."

Margaret Parton also confirmed the Hub's commitment to aiding the roll-out of crucial innovations in medical technology: "It is vital that new life-saving, cost-effective technologies are adopted as quickly as possible through the NHS. The National Technology Adoption Hub will streamline and speed up the process for the benefit of patients and the NHS as a whole."

The three technologies to be reviewed in the first wave of the Hub project are: Deltex Medical's CardioQ Oesophageal Doppler monitoring machine, the CT3000 Non-Invasive Bladder Analysis for Men manufactured by Mediplus and the 12 Lead ECG Telemedicine GP Programme developed by Broomwell Healthwatch*. All three products are proven, cost-effective measures that have delivered real benefits to trusts and patients where implemented, and could transform the standards of care up and down the country.

Ewan Phillips, Managing Director of Deltex Medical, commented: "We are delighted that the CardioQ has been selected for the first wave of the new National Technology Adoption Hub. If rolled out across the NHS, we believe it could lead to savings of 500 million a year."

James Urie a Director of Mediplus commented: "The CT3000 is an effective, non-invasive procedure that provides an accurate diagnosis, saving the NHS - and patients - time, inconvenience and money." The Telemedicine GP Programme offers similar benefits in primary care: "We can provide immediate verbal ECG reports to GPs with written reports following a few minutes later, thanks to our extremely portable device, which can be used either in the surgery or at the patient's home," said Broomwell Healthwatch Chief Executive Joshua Rowe.

The Technology Adoption Hub will work with host trusts to review adoption of the technologies and gain greater understanding of the challenges and benefits of adoption at a component level, a local systems and whole systems level, across the NHS and beyond the NHS to social services and employment.

To find out more about the National Launch Event, please click on the 'Events' tab.



Regards and happy reading,

THE COUNT!

Ticking up nicely last couple of days.
The government is pushing everything at the moment, so the time scale re the CardioQ project might be shorter than we think.
And yes I have altered my mind re my previous comment," Don't hold your breath for a result"
Labour are pushing for votes, so they will be looking for good news to release whenever possible, re the NHS among others.
As previously said, with all the papers already published, how much more research into the CardioQ can there be.
Lets hope procrastination is not the order of the day.

THE COUNT--->GREEKMAN

I don't believe it. This thread goes dead and then we both end up posting around the same time. Hope you haven't missed the post I just made before yours.

You should find it of some interest.

Kalon Savvadokiriakon, re goumbarre. :-)

Regards,

THE COUNT!

The Count,

Great minds as they say. No I didn't miss your post, as I saw it straight after I posted mine. Very interesting, the futures looking brighter than its been for a long time. Would buy more but don't wish to overstretch Deltex in my portfolio.

THE COUNT--->ALL

It looks as if we have finally made the BBC news at long last. Maybe there is an ever brightening light at the end of our tunnel.

Regards,

THE COUNT!


http://news.bbc.co.uk/1/hi/health/7029722.stm

NHS to speed up technology use

A scheme to speed up the introduction of cutting-edge technology in the NHS has been launched.

The NHS has long been criticised for being slow to adopt new gadgets.
Around 15 life-saving technologies will be introduced over three years, including a blood flow monitor which could save the NHS 500m a year.

The NHS Technology Adoption Hub, based in Manchester, was set up after an advisory group found innovations were not reaching patients.

The Healthcare Industries Task Force, set up to promote better use of medical technology within the NHS, concluded three years ago that better promotion was needed for new ideas.

In 2005, the Health Select Committee warned the NHS was lagging behind many other countries in the take-up of modern equipment and spent less than the European average on medical technology.

One of the devices to be looked at under the new programme - the CardioQ Oesophageal Doppler machine - monitors the amount of blood circulating in patients undergoing major surgery.

It tells doctors if the patient needs additional fluid, helping them to recover much more quickly after the operation.

The Hub is also looking at a machine to diagnose whether men with an enlarged prostate would benefit from surgery.

An ECG machine which can be used by GPs in their practice and the results read remotely by experts, reducing the need for patients to attend hospital clinics, is also being introduced.

Barriers

Each technology will be implemented in three trusts before adoption is encouraged across the whole of the NHS.

Margaret Parton, head of the National Technology Adoption Hub said all the technologies chosen had been proven to be effective but for some reason most people did not have access to them.

"It is vital that new life-saving, cost-effective technologies are adopted as quickly as possible through the NHS.
"The National Technology Adoption Hub will streamline and speed up the process."

She said individual trusts were nervous about taking the "risk" of buying expensive equipment that wouldn't be used.

"One of the biggest issues is that adopting new technology is very disruptive - what we're doing is breaking down those barriers and supporting trusts."

Health minister Lord Ara Darzi, who is also a practising surgeon, said: "It is encouraging to see the NHS continually striving to find the best standards of care, using the latest available techniques, for its patients."

Richard Phillips, a spokesman for the Medical Technology Group, a campaign body, said he hoped the Hub would speed up the process.

"Medical technologies are going through several different appraisal channels, including the National Institute for Health and Clinical Excellence, yet even when approved they are not being widely used in the NHS.

"It simply takes too long for new developments to be taken up for use in the NHS. This Hub has the potential to change that."

He added there were some "serious challenges" in getting already approved technologies implemented more quickly and consistently across the NHS.
Story from BBC NEWS:

The Count,

Nice article. Shame the sp didn't open higher today. No trades as yet either.
Although a steady tick up last week what this share really needs to get it moving is a bloody good jolt from one of those heart shock (defibrillator) thingies.
Trying not to allow heart to rule head, but within a couple of years I can see pundits looking back at this share and stating that it was one of the market investment bargains of 2007.

I agree: patience is what we need - as patients will surely benefit from the CardioQ. Wherever the it's been trialled, it's always been successful.

Level 2 is all up today so maybe the sp will start to reflect the value of this company. I'm holding on to my shares.

nice news re NHS
surely a re-rating now beckons?

Suddenly burst into life.
2517

Not been following things today so with sells beating buys, with a steady sp increase I have no idea who has been chasing the price, still no complaint.

deleted due to error.

4 trades all day. Talk about watching and waiting.
Still prepared to wait.

Yet more good news.

Yes great news but until the powers that be see the bl***y obvious it won't have much effect to the sp.

With statements such as these...."There are improved outcomes for patients, with reduced morbidity rates, fewer complications and rapid recovery. Length of stay has been reduced from approximately 9-10 days per patient to just 6 days." It's a no brainer as they say. The problem is with NHS management the words No Brain appear to be a more apt statement.

Always good to see directors having faith in their company.

Ewan Phillips purchased 50,000 shares at 21.25 pence each on Nov 21 and 10,000 shares at 21.17 pence each on Nov 23, lifting his stake in the company to 977,156 shares or 1.06 pct.